Skip to content

Clinical trials

Phase 2 Genetic Diseases, Inborn trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Phase 2 Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20062
20073
20094
20102
20115
20123
20131
20141
20161
20171
20186
20193
20201
20214
20223
20241
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated11
Unknown status6
Recruiting6
Enrolling by invitation3
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)6
Vertex Pharmaceuticals Incorporated4
National Cancer Institute (NCI)3
Novartis Pharmaceuticals3
QED Therapeutics, a BridgeBio company3
Emory University2
Kastle Therapeutics, LLC2
National Institute of Neurological Disorders and Stroke (NINDS)2
National Institutes of Health Clinical Center (CC)2
Pharming Technologies B.V.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn70
Rare Diseases14
Metabolic Diseases8
Musculoskeletal Diseases8
Nervous System Diseases8
Anemia, Sickle Cell7
Cystic Fibrosis7
Hematologic Diseases7
Infant, Newborn, Diseases6
Metabolism, Inborn Errors6

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.